NCT Number: NCT04167969
Phase: Phase 1
Trial Summary: The purpose of this study is to see whether using the 64Cu-NOTA-PSMA-PEG-Cy5.5-C’ dot tracer is a safe way to identify tumor cells before and during surgery for prostate cancer. Th – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s):
Acronym:
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives